Lawsuit for Investors in (NYSE MKT: TXMD) Shares Against TherapeuticsMD Inc. Announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / May 1, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain purchasers of (NYSE MKT: TXMD) shares against TherapeuticsMD Inc. over alleged Violations of Securities Laws.

Investors, who purchased shares of TherapeuticsMD Inc. (NYSE MKT: TXMD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

On April 10, 2017, TherapeuticsMD Inc. announced receipt of a letter from the U.S. Food and Drug Administration (“FDA”) stating that its ongoing review of the Company’s New Drug Application (NDA) for TX-004HR has discovered deficiencies that preclude discussion of labeling and postmarketing requirements/commitments at this time.

On April 19, 2017, a lawsuit was filed against TherapeuticsMD Inc. over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that: the Company’s New Drug Application (NDA) submission for TX-004HR was deficient, that the NDA submission for TX-004HR was not supported by the complete TX-004HR clinical program and/or the clinical program was deficient, and that the deficient NDA would likely cause a delay of the FDA’s potential approval of the TX-0004HR NDA.

The plaintiff seeks to recover losses for certain investors who purchased (NYSE MKT: TXMD) shares.

Those who purchased TherapeuticsMD Inc. (NYSE MKT: TXMD) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 461393